Clinical Trials Directory

Trials / Completed

CompletedNCT03066713

Post-prandial Glucose Response From Phytochemical Rich Potato Products

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Purdue University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Assess the impact of high antioxidant potato products on postprandial glycemic response and subsequent appetite and food intake.

Detailed description

Preliminary results from anthocyanin rich potato products suggest that a reduced postprandial glycemic response might be expected from certain types of potato products and that phenolic antioxidants may play a critical role in predicting the physiological response from potato products. Further, if consumed early in the day, such as at breakfast, a reduced glycemic response may serve to mitigate appetite and food consumption later in the day. Investigators aim to better understand how characteristics of commercial potato products (i.e. frozen potato products) with different phenolic profiles and content, may alter postprandial glycemic response and subsequent appetitive behavior. Specifically, investigators will assess the glycemic response from a serving of potato products in the morning using continuous glucose monitoring. Further, appetite and subsequent food consumption later in the day will be assessed through appetite logs and continuous glucose monitoring.

Conditions

Interventions

TypeNameDescription
OTHERSkin Off French FrySkin Off French Fries will be provided at breakfast and lunch
OTHERSkin On French FrySkin On French Fries will be provided at breakfast and lunch
OTHERHash brownHash brown potatoes will be provided at breakfast and lunch.
OTHERCarbohydrate controlA pancake will be provided at breakfast, and pretzels will be provided at lunch.

Timeline

Start date
2017-01-31
Primary completion
2017-06-25
Completion
2017-06-25
First posted
2017-02-28
Last updated
2018-01-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03066713. Inclusion in this directory is not an endorsement.